Sensei Biotherapeutics Inc (SNSE)

NASDAQ
Currency in USD
9.1500
+0.1200(+1.33%)
Closed·
SNSE Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SNSE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.80009.1500
52 wk Range
5.000017.4000
Key Statistics
Edit
Prev. Close
9.15
Open
9.015
Day's Range
8.8-9.15
52 wk Range
5-17.4
Volume
3.81K
Average Volume (3m)
9.87K
1-Year Change
-26.46%
Book Value / Share
25.38
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SNSE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
67.5000
Upside
+637.70%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Sensei Biotherapeutics Inc News & Analysis

Show more

Sensei Biotherapeutics Company Profile

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company’s Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company’s pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its solnerstotug program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.

Compare SNSE to Peers and Sector

Metrics to compare
SNSE
Peers
Sector
Relationship
P/E Ratio
−0.4x−3.9x−0.5x
PEG Ratio
−0.10−0.010.00
Price/Book
0.4x1.5x2.6x
Price / LTM Sales
-15.9x3.0x
Upside (Analyst Target)
-174.0%49.2%
Fair Value Upside
Unlock13.6%7.4%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 67.5000
(+637.70% Upside)

Earnings

Latest Release
May 06, 2025
EPS / Forecast
-0.27 / -0.23
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

SNSE Income Statement

FAQ

What Is the Sensei Biotherapeutics (SNSE) Stock Price Today?

The Sensei Biotherapeutics stock price today is 9.15.

What Stock Exchange Does Sensei Biotherapeutics Trade On?

Sensei Biotherapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Sensei Biotherapeutics?

The stock symbol for Sensei Biotherapeutics is "SNSE."

What Is the Sensei Biotherapeutics Market Cap?

As of today, Sensei Biotherapeutics market cap is 11.53M.

What Is Sensei Biotherapeutics's Earnings Per Share (TTM)?

The Sensei Biotherapeutics EPS (TTM) is -23.08.

When Is the Next Sensei Biotherapeutics Earnings Date?

Sensei Biotherapeutics will release its next earnings report on 30 Jul 2025.

From a Technical Analysis Perspective, Is SNSE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sensei Biotherapeutics Stock Split?

Sensei Biotherapeutics has split 1 times.

How Many Employees Does Sensei Biotherapeutics Have?

Sensei Biotherapeutics has 254 employees.

What is the current trading status of Sensei Biotherapeutics (SNSE)?

As of 08 Jul 2025, Sensei Biotherapeutics (SNSE) is trading at a price of 9.15, with a previous close of 9.15. The stock has fluctuated within a day range of 8.80 to 9.15, while its 52-week range spans from 5.00 to 17.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.